| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 10.05.
| NeurogesX Inc - 10-Q, Quarterly Report | | 2 | SEC Filings |
| 03.05.
| Robbins Umeda LLP Announces an Investigation of NeurogesX, Inc. | | 36 | Business Wire |
| Shareholder rights firm Robbins
Umeda LLP is investigating possible breaches of fiduciary duty and
other violations of the law by certain officers and directors at
...
Mehr lesen zu:
Robbins Umeda LLP Announces an Investigation of NeurogesX, Inc. | |
| 23.04.
| The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in NeurogesX, Inc. of Class Action Lawsuit | | 49 | PR Newswire |
| NEW YORK, April 23, 2012 /PRNewswire/ --Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf...
Mehr lesen zu:
The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in NeurogesX, Inc. of Class Action Lawsuit | |
| 20.04.
| NeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance | | 5 | Benzinga.com |
| 17.04.
| UPDATE 1-NeurogesX seeks partners for pain drugs | | 1 | Reuters.com |
| 17.04.
| NeurogesX (NGSX) Taps Advisor in Evaluating Development Objectives | | - | StreetInsider.com |
| 17.04.
| NeurogesX Engages JSB-Partners to Execute Business Development Strategy | | 2 | Benzinga.com |
| 11.04.
| Hot Stock: NeurogesX, Shares Gain 27.2% | | - | SmarTrend |
| 11.04.
| NeurogesX (NGSX) Gets FDA Acceptance for End-of-Phase 2 Meeting for NGX-1998 | | 7 | StreetInsider.com |
| 10.04.
| NeurogesX: New 52-Week Low Set Today | | - | SmarTrend |
| 04.04.
| NeurogesX: The Losing Streak Continues | | 5 | SmarTrend |
| 08.03.
| NeurogesX (NGSX) Tops Q4 EPS by 7c; Announces Restructuring, Cutting 43 Jobs; Received CRL, FDA Seeking Added Data from Qutenza Trials | | 11 | StreetInsider.com |
| 10.02.
| XFRA I8Z: WIEDERAUFNAHME/RESTART | | 44 | Xetra Newsboard |
| DIE FOLGENDE AKTIE WIRD MIT SOFORTIGER WIRKUNG WIEDER IN DEN HANDEL AUFGENOMMEN: THE FOLLOWING SHARE IS RESUMED TRADING WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN NeurogesX Inc. I8Z...
Mehr lesen zu:
XFRA I8Z: WIEDERAUFNAHME/RESTART | |
| 09.02.
| NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza | | 21 | StreetInsider.com |
| 09.02.
| XFRA I8Z: AUSSETZUNG/SUSPENSION | | 26 | Xetra Newsboard |
| DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT: THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL NEUROGESX I8Z US6412521014 BAW/UFN
Mehr lesen zu:
XFRA I8Z: AUSSETZUNG/SUSPENSION | |
| 07.02.
| FDA Concerned with Effectiveness of NeurogesX's (NGSX) Qutenza Patch | | 13 | StreetInsider.com |
